Advertisement

Banner C5 Communications Life Sciences IP Summit 2014 Amsterdam 600x60px
Document › Details

Clavis Pharma ASA. (1/18/12). "Press Release: Clavis Pharma. Raises NOK 163 Million in Private Placement". Oslo.

Organisations Organisation Clavis Pharma ASA
  Today Aqualis ASA
  Group Aqualis ASA
  Organisation 2 Braganza AS
Products Product elacytarabine
  Product 2 CP-4126 (CO-101)
Index term Index term Clavis Pharma–SEVERAL: investment, 201201 private placement NOK163m 2.86m new shares NOK53/share
Persons Person Hellebø, Olav (Clavis Pharma 201108 CEO)
  Person 2 Manum, Gunnar (Clavis Pharma 201107 CFO)
     


   
Record changed: 2013-06-09

Advertisement

Highl Successful LC/MS Niche Player Is Looking for a Junior Partner 600x60px

More documents for Aqualis ASA


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Highl Successful LC/MS Niche Player Is Looking for a Junior Partner 600x60px




» top

Advertisements

The Events Group Pharm Connect Congress 2015 Budapest February 120x180px Highl Successful LC/MS Niche Player Is Looking for a Junior Partner 120x240px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Banner [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px